Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > It’s now October and still not trading?
View:
Post by ETalien on Oct 08, 2020 9:37am

It’s now October and still not trading?

Why is this not trading?
Comment by Moonshiner592 on Oct 08, 2020 10:47am
At this point in time Rob should have some NR's ready to publish ... and should be applying for trade resumption through the TSE ...  We should see something between the 13th and 23rd of this month .. 
Comment by LI33VESTREAM on Oct 08, 2020 1:08pm
This post has been removed in accordance with Community Policy
Comment by ETalien on Oct 08, 2020 3:10pm
I have been in the markets for a very, very long time.. and I do mean a very, very long time and I haven't had the wonderful experience of waiting for a trade resumption this long. Unbelievable!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities